Atai Life Sciences N.V. (ATAI) Price Target Decreased by 15.35% to 10.90

2d ago, source: Fintel on MSN

The average one-year price target for Atai Life Sciences N.V. (NasdaqGM:ATAI) has been revised to 10.90 / share. This is an ...

atai Life Sciences N.V. (ATAI) Upgraded to Buy: Here's Why

5mon ago, source: Hosted on MSN

atai Life Sciences N.V. (ATAI) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces ...

ATAI Life Sciences NV ATAI

7d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

ATAI Life Sciences N.V.

1mon ago, source: CNN

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand ...

ATAI Life Sciences NV

15d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

ATAI Life Sciences N.V.

22d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

ATAI Life Sciences N.V. Common Shares (ATAI)

1y ago, source: Nasdaq

Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on ...